Potential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges.

Introduction: Japanese encephalitis (JE) remains a public health threat in Asia. Although several vaccines have been licensed, ∼ 67,900 cases of the disease are estimated to occur annually, probably because the vaccine coverage is low. Therefore, effective antiviral drugs are required to control JE.